Venkat Pharma (Delisted) share price
BSE: 532093
Venkat Pharma Ltd. · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary
Last traded ₹3.40 on 18 May 2015
Delisted on 11 May 2018.
Last announcements
The company's own last announcements before its shares stopped trading, routine notices left out.
Feb 2015
Nov 2014
Oct 2014
Sep 2014
Jun 2014
Results for the quarter to Dec 2014
Standalone: the listed company alone, without its subsidiaries. ₹ crore.
- Net profitNet profit. What is left of revenue and other income after every cost, interest and tax. Net profit in the glossary
- ₹0.00 Cr
From revenue to net profit, ₹ crore
- Profit before tax0.0
- Net profit0.0
Venkat Pharma results by quarter
Standalone: the listed company alone, without its subsidiaries. Latest quarter to Dec 2014. Results for the quarter to Mar 2015 were due by 30 May 2015, 60 days after it ends. Every company's dates are on the results calendar.
Revenue and net profit by quarter, ₹ crore
- Revenue
- Net profit
- Loss
A loss in 12 of the 12 quarters shown
Operating and net margin by quarter, per cent
- Operating margin
- Net margin
| ₹ crore | Mar 2010 | Jun 2010 | Sep 2010 | Dec 2010 | Mar 2011 | Jun 2011 | Sep 2011 | Dec 2011 | Mar 2012 | Jun 2012 | Sep 2012 | Dec 2012 | Mar 2013 | Jun 2013 | Sep 2013 | Dec 2013 | Mar 2014 | Jun 2014 | Sep 2014 | Dec 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Depreciation and amortisationDepreciation and amortisation. The part of the cost of plant, buildings and other long-lived assets charged against each year they are used. Depreciation and amortisation in the glossary | 0.01 | – | – | – | 0.02 | – | – | – | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | – | – | – | – |
| Other incomeOther income. Income from outside the main business, such as interest on deposits, dividends received and gains on investments. Other income in the glossary | – | – | – | – | 0.00 | 0.00 | – | – | 0.00 | – | – | – | – | – | – | – | – | – | – | – |
| Profit before tax | −0.18 | −0.01 | −0.01 | −0.01 | −0.03 | 0.00 | −0.01 | 0.00 | −0.02 | −0.01 | −0.02 | −0.01 | −0.01 | 0.00 | −0.01 | −0.01 | 0.00 | −0.01 | −0.01 | 0.00 |
| Tax | 0.01 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Net profit | −0.19 | −0.01 | −0.01 | −0.01 | −0.03 | 0.00 | −0.01 | 0.00 | −0.02 | −0.01 | −0.02 | −0.01 | −0.01 | 0.00 | −0.01 | −0.01 | 0.00 | −0.01 | −0.01 | 0.00 |
Earnings per share in rupees, restated for later splits and bonuses.
7 years at a glance
Standalone: the listed company alone, without its subsidiaries. ₹ crore, years to March.
Revenue, net profit and borrowings, ₹ crore
- Revenue
- Net profit
- Borrowings
- Loss
Peak revenue ₹1.05 Cr, year to Mar 2008; lowest ₹0.09 Cr, year to Mar 2009A loss in 7 of the 7 years shown
Operating and net margin, per cent
- Operating marginOperating margin. Operating profit before depreciation as a percentage of revenue: how much of each rupee of sales is left after running costs. Operating margin in the glossary
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. Net margin in the glossary
Results for the year to Mar 2014
Standalone: the listed company alone, without its subsidiaries. ₹ crore.
From revenue to net profit
- Profit before tax0.0
- Net profit0.0
Profit and loss
Standalone, ₹ crore, years to March.
| ₹ crore | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 |
|---|---|---|---|---|---|---|---|
| Revenue from operations | 1.05 | 0.09 | – | – | – | – | – |
| Operating expenses. What the business spent to run itself in the period, materials, staff and other costs, before depreciation, interest and tax. Operating expenses in the glossary | – | 0.46 | – | – | – | – | – |
| Materials and goods boughtCost of materials and goods. Raw materials used and goods bought for resale in the period, adjusted for the change in stock held. Cost of materials and goods in the glossary | 1.52 | – | – | – | – | – | – |
| Employee costsEmployee costs. Salaries, wages, bonuses and other benefits paid to staff in the period. Employee costs in the glossary | – | 0.02 | – | – | – | – | – |
| Other expensesOther expenses. Every operating cost besides materials and staff: power, rent, freight, repairs, marketing and the like. Other expenses in the glossary | – | 0.37 | – | – | – | – | – |
| Operating profit before depreciationOperating profit before depreciation (EBITDA). Revenue less operating expenses: what the business earns from its operations before depreciation, interest and tax. Operating profit before depreciation (EBITDA) in the glossary | – | −0.37 | – | – | – | – | – |
| Operating margin | – | −391.9% | – | – | – | – | – |
| Employee costs, % of revenueEmployee costs, % of revenue. Salaries, wages and other staff costs divided by revenue, times 100. Employee costs, % of revenue in the glossary | – | 19.3% | – | – | – | – | – |
| Other expenses, % of revenueOther expenses, % of revenue. Operating costs besides materials and staff divided by revenue, times 100; with the two above and the operating margin it makes 100. Other expenses, % of revenue in the glossary | – | 398.7% | – | – | – | – | – |
| Depreciation and amortisation | 0.06 | 0.05 | 0.04 | 0.02 | 0.02 | 0.02 | – |
| Operating profit after depreciationOperating profit after depreciation (EBIT). Operating profit before depreciation, less depreciation and amortisation. Operating profit after depreciation (EBIT) in the glossary | – | −0.42 | – | – | – | – | – |
| Other income | – | – | – | 0.00 | 0.00 | – | – |
| Finance costsFinance costs. Interest and the other costs of borrowing in the period. Finance costs in the glossary | – | 0.01 | – | – | – | – | – |
| Profit before tax | −2.74 | −0.44 | −0.24 | −0.06 | −0.04 | −0.04 | −0.02 |
| Tax | – | – | 0.01 | – | – | – | – |
| Net profit | −2.74 | −0.44 | −0.25 | −0.06 | −0.04 | −0.04 | −0.02 |
| Net margin | −261.0% | −468.1% | – | – | – | – | – |
Materials, employee costs and other expenses are shown for the years they add up to operating expenses; for the year to Mar 2009 they do not, so they are left blank. Operating expenses, operating profit before depreciation and operating profit after depreciation are left blank for the year to Mar 2008: the statement does not state its finance costs, which operating profit is worked out from, so operating profit is not given. Operating expenses, operating profit before depreciation and operating profit after depreciation are left blank for the years to Mar 2010, Mar 2011, Mar 2012 and Mar 2013: the statement does not state its revenue or finance costs, which operating profit is worked out from, so operating profit is not given. Operating expenses, operating profit before depreciation and operating profit after depreciation are left blank for the year to Mar 2014: the statement does not state its revenue, finance costs or depreciation, which operating profit is worked out from, so operating profit is not given.
Ratios
Standalone, years to March.
| Ratio | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 |
|---|---|---|---|---|---|---|
| Revenue growthRevenue growth. This year's revenue less last year's, divided by last year's, times 100; blank where last year's is not above nought. Revenue growth in the glossary | −91.0% | – | – | – | – | – |
Interest cover is left blank for the year to Mar 2009: operating profit after depreciation is a loss, and a loss covers no interest bill.
Where the return came from
Yearly rates to Mar 2014, per-share figures restated for splits and bonuses.
| Over | Return a year | Earnings growth | Change in P/E | Dividend yield |
|---|---|---|---|---|
| 1 year | −34.8% | – | – | 0.0% |
| 3 years | −21.2% | – | – | 0.0% |
| 5 years | −9.5% | – | – | 0.0% |
Return is price growth plus the average dividend yield. Change in P/E is (1 + price growth) / (1 + earnings growth) - 1, so the parts compound rather than add. Earnings growth and the change in P/E are left empty where earnings per share at either end of the window was a loss or is not on record.
Venkat Pharma share price by year
Each calendar year to 2015.
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2015 | 3.40 | +32.3% | 3.57 | 2.69 |
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before. The 2015 close is its last trade, on 18 May 2015.
Recent sessions
The 10 trading days to 18 May 2015, as traded on BSE.
| Date | Open | High | Low | Close | Average price | Volume |
|---|---|---|---|---|---|---|
| 18 May 2015 | 3.72 | 3.72 | 3.40 | 3.40 | 3.70 | 105 |
| 13 Apr 2015 | 3.23 | 3.57 | 3.23 | 3.57 | 3.24 | 8,300 |
| 6 Apr 2015 | 3.09 | 3.40 | 3.09 | 3.40 | 3.09 | 9,025 |
| 2 Mar 2015 | 3.25 | 3.25 | 3.25 | 3.25 | 3.25 | 5 |
| 23 Feb 2015 | 3.10 | 3.10 | 3.10 | 3.10 | 3.10 | 1 |
| 9 Feb 2015 | 2.96 | 2.96 | 2.96 | 2.96 | 2.96 | 1 |
| 2 Feb 2015 | 2.82 | 2.82 | 2.82 | 2.82 | 2.82 | 5 |
| 12 Jan 2015 | 2.69 | 2.69 | 2.69 | 2.69 | 2.69 | 500 |
| 29 Dec 2014 | 2.57 | 2.57 | 2.57 | 2.57 | 2.57 | 100 |
| 22 Dec 2014 | 2.45 | 2.45 | 2.45 | 2.45 | 2.45 | 1 |
Prices in ₹ per share as traded, not adjusted.
Company details
- BSE code
- 532093
- ISIN
- INE346F01018
- Website
- www.venkatpharmaltd.com
- CIN
- L24239AP1989PLC010272
- Corporate identity number, the registrar of companies' code for it
- Incorporated
- 1989
- Registered office
- B - 4 President Banjara road 2 Banjara Hills, Hyderabad 500034, Telangana
- Share registrar
- Bigshare Services Pvt. Ltd
- Keeps the register of shareholders and handles transfers and dividend payments